Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 20.975 USD -2.21%
Market Cap: 3B USD
Have any thoughts about
Denali Therapeutics Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Denali Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(108)
(94)
(85)
(88)
(91)
(123)
(137)
(36)
(52)
(55)
(66)
(198)
(215)
(216)
(228)
71
58
56
30
(291)
(286)
(284)
(303)
(326)
(371)
(128)
(125)
(145)
(137)
(420)
(427)
Depreciation & Amortization
2
3
3
3
3
4
6
7
9
9
8
8
8
8
9
9
9
9
9
9
9
9
8
10
18
19
19
17
9
9
9
Stock-Based Compensation
4
5
6
4
7
10
15
19
23
32
35
38
42
41
45
50
61
69
77
85
90
93
97
100
102
104
107
108
108
106
104
Other Non-Cash Items
10
10
5
5
7
9
13
16
20
29
32
34
38
36
40
50
62
74
84
94
100
100
100
95
87
78
69
60
43
43
44
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
5
5
0
3
56
61
57
63
8
3
15
4
(6)
(4)
34
286
293
271
246
(23)
(56)
(47)
(44)
(24)
34
(270)
(295)
(290)
(327)
(22)
12
Cash from Operating Activities
(91)
N/A
(76)
+17%
(77)
-1%
(77)
+0%
(24)
+68%
(48)
-100%
(61)
-27%
50
N/A
(14)
N/A
(15)
-10%
(11)
+30%
(152)
-1 317%
(176)
-16%
(176)
0%
(146)
+17%
416
N/A
421
+1%
410
-3%
368
-10%
(211)
N/A
(233)
-10%
(222)
+5%
(238)
-7%
(245)
-3%
(231)
+5%
(302)
-30%
(332)
-10%
(358)
-8%
(413)
-15%
(391)
+5%
(363)
+7%
Investing Cash Flow
Capital Expenditures
(7)
(6)
(4)
(3)
(3)
(3)
(3)
(3)
(5)
(15)
(17)
(18)
(17)
(7)
(5)
(3)
(5)
(6)
(7)
(9)
(10)
(12)
(16)
(18)
(17)
(20)
(16)
(13)
(12)
(11)
(13)
Other Items
(197)
(125)
39
(38)
(355)
(347)
(318)
(284)
11
54
61
166
159
55
(209)
(620)
(630)
(502)
(342)
(13)
(104)
(111)
(39)
(124)
(100)
(17)
64
262
(99)
(169)
(175)
Cash from Investing Activities
(204)
N/A
(131)
+36%
35
N/A
(41)
N/A
(358)
-769%
(349)
+2%
(321)
+8%
(287)
+11%
6
N/A
39
+563%
44
+12%
148
+236%
142
-4%
48
-66%
(214)
N/A
(623)
-192%
(635)
-2%
(507)
+20%
(348)
+31%
(22)
+94%
(114)
-428%
(123)
-8%
(55)
+56%
(141)
-159%
(116)
+18%
(37)
+68%
49
N/A
249
+412%
(111)
N/A
(181)
-63%
(188)
-4%
Financing Cash Flow
Net Issuance of Common Stock
301
8
1
296
389
392
392
98
6
6
6
6
201
202
627
635
443
446
24
19
17
14
16
311
311
315
313
18
516
514
517
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(24)
Other
0
0
0
0
0
(1)
(1)
(1)
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
301
N/A
8
-97%
1
-91%
296
+42 229%
389
+31%
391
+0%
391
+0%
97
-75%
5
-95%
6
+23%
6
+2%
6
+5%
201
+3 145%
202
+0%
627
+210%
635
+1%
443
-30%
446
+1%
24
-95%
19
-19%
17
-12%
14
-16%
16
+13%
311
+1 830%
311
+0%
315
+1%
313
-1%
18
-94%
516
+2 798%
514
0%
493
-4%
Change in Cash
Net Change in Cash
6
N/A
(199)
N/A
(41)
+79%
179
N/A
7
-96%
(7)
N/A
8
N/A
(140)
N/A
(3)
+98%
30
N/A
39
+32%
2
-94%
168
+7 196%
74
-56%
268
+261%
428
+59%
228
-47%
348
+53%
44
-87%
(214)
N/A
(330)
-55%
(331)
0%
(276)
+16%
(75)
+73%
(37)
+51%
(23)
+37%
30
N/A
(91)
N/A
(7)
+92%
(57)
-664%
(57)
0%
Free Cash Flow
Free Cash Flow
(98)
N/A
(82)
+16%
(81)
+2%
(80)
+2%
(27)
+66%
(51)
-91%
(65)
-26%
47
N/A
(19)
N/A
(30)
-59%
(27)
+9%
(170)
-523%
(193)
-14%
(183)
+5%
(150)
+18%
413
N/A
416
+1%
404
-3%
362
-11%
(220)
N/A
(243)
-11%
(234)
+4%
(254)
-9%
(263)
-3%
(248)
+6%
(321)
-30%
(347)
-8%
(371)
-7%
(425)
-15%
(402)
+5%
(376)
+7%

See Also

Discover More